Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-086261
Filing Date
2025-06-13
Accepted
2025-06-13 16:30:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8986
  Complete submission text file 0000950170-25-086261.txt   10418
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Subject) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92734 | Film No.: 251047069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O HCW BIOLOGICS, INC. 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address
Wong Hing C (Filed by) CIK: 0001866258 (see all company filings)

Type: SCHEDULE 13D/A